HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

The procognitive effects of 5-HT6 receptor ligands in animal models of schizophrenia.

Abstract
In addition to positive and negative symptoms, cognitive deficits are increasingly being recognized as a core feature of schizophrenia. Neurocognitive impairments are strongly associated with functional outcomes; thus, the treatment of cognitive impairments is of central importance. A large body of evidence suggests that the serotonin 6 (5-HT6) receptors may be potential targets for cognitive improvement. Clinical and preclinical studies have supported the notion that using 5-HT6 receptor antagonists is a promising component in the treatment of cognitive dysfunctions associated with aging and Alzheimer's disease. However, less is known about the efficacy of this strategy in the treatment of schizophrenia-like cognitive disturbances. The purpose of this review is to summarize existing data on the effects of 5-HT6 receptor antagonists in animal experiments, utilizing tasks that assess cognitive domains that are relevant to the cognitive deficits characterizing schizophrenia. This review focuses primarily on animal models of schizophrenia that are based on the blockade of N-methyl-d-aspartate receptors; however, when relevant, data obtained in other models are also discussed. The putative procognitive actions of 5-HT6 agonists are also reviewed. Finally, the mechanisms that are putatively responsible for the procognitive effects of 5-HT6 receptor ligands are briefly discussed.
AuthorsAgnieszka Nikiforuk
JournalReviews in the neurosciences (Rev Neurosci) Vol. 25 Issue 3 Pg. 367-82 ( 2014) ISSN: 0334-1763 [Print] Germany
PMID24501158 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't, Review)
Chemical References
  • Ligands
  • Receptors, Serotonin
  • Serotonin Antagonists
  • serotonin 6 receptor
Topics
  • Animals
  • Cognition Disorders (drug therapy, etiology, metabolism)
  • Disease Models, Animal
  • Humans
  • Ligands
  • Receptors, Serotonin (metabolism)
  • Schizophrenia (complications)
  • Serotonin Antagonists (therapeutic use)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: